- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
ATRN Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP16370b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP16370b-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
ATRN Antibody (C-term) - Product info | |
| Application | WB
|
| Primary Accession | O75882 |
| Other Accession | Q99J86, Q9WU60, NP_647537.1, NP_647538.1 |
| Reactivity | Human |
| Predicted | Mouse, Rat |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 158537 Da |
ATRN Antibody (C-term) - Additional info | |
| Gene ID 8455 | |
| Other Names ATRN; KIAA0548; MGCA; Attractin; DPPT-L; Mahogany homolog | |
| Target/Specificity This ATRN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1391-1421 amino acids from the C-terminal region of human ATRN. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions ATRN Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
ATRN Antibody (C-term) - Protein Information | |
| Name ATRN | |
| Synonyms KIAA0548, MGCA | |
| Function Involved in the initial immune cell clustering during inflammatory response and may regulate chemotactic activity of chemokines. May play a role in melanocortin signaling pathways that regulate energy homeostasis and hair color. Low-affinity receptor for agouti (By similarity). Has a critical role in normal myelination in the central nervous system (By similarity) | |
| Cellular Location Isoform 1: Cell membrane; Single-pass type I membrane protein Isoform 3: Secreted. | |
| Tissue Location Isoform 2 is detected in plasma (at protein level). Expressed and secreted by activated T-lymphocytes Expressed at low to moderate levels in peripheral blood leukocytes, spleen, lymph node, tonsil, bone marrow and fetal liver. At very low levels found in thymus. Isoform 2 is the major isoform in peripheral blood leukocytes | |
ATRN Antibody (C-term) - Related products
ATRN Antibody (C-term) - Application data
-
ATRN Antibody (C-term) (Cat. #AP16370b) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the ATRN antibody detected the ATRN protein (arrow).
ATRN Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Multiple transcript variants encoding different isoforms exist for this gene. One of the isoforms is a membrane-bound protein with sequence similarity to the mouse mahogany protein, a receptor involved in controlling obesity. The other isoform is a secreted protein involved in the initial immune cell clustering during inflammatory responses that may regulate the chemotactic activity of chemokines.
REFERENCES
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Radhakrishnan, Y., et al. Biol. Reprod. 81(4):647-656(2009) Nan, H., et al. Int. J. Cancer 125(4):909-917(2009) Fernandez, L.P., et al. Exp. Dermatol. 18(7):634-642(2009) Friedrich, D., et al. Biol. Chem. 388(2):155-162(2007)